CHARLEBOIS: GLP-1 drugs becoming Canada’s $3.4 billion food disruption – Oxysage

CHARLEBOIS: GLP-1 drugs becoming Canada’s $3.4 billion food disruption

We learned last week that Apotex Inc., Canada’s largest drug manufacturer, has received approval from Health Canada to market a generic version of Ozempic. Read More

About admin